Recombinant CD47 (Magrolimab Biosimilar) anticorps
-
- Antigène Tous les produits CD47 (Magrolimab Biosimilar)
- CD47 (Magrolimab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp CD47 (Magrolimab Biosimilar) est non-conjugé
-
Application
- ELISA
- Fonction
- Magrolimab Biosimilar - Anti-CD47 mAb
- Attributs du produit
- Antibody Type: IgG4-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Classe de qualité
- Research Grade
- Isotype
- IgG4 kappa
-
anti-CD47 (Magrolimab Biosimilar) antibody
Research Grade Reactivité: Humain ELISA, FACS Hôte: Humanized Mouse Chimeric unconjugated Recombinant Antibody
anti-CD47 (Magrolimab Biosimilar) antibodyResearch Grade Reactivité: Humain ELISA, FACS Hôte: Human Monoclonal unconjugated Recombinant Antibody
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Stock
- -80 °C
- Stockage commentaire
- store at -80°C
-
- Antigène
- CD47 (Magrolimab Biosimilar)
- Abstract
- CD47 (Magrolimab Biosimilar) Produits
- Classe de substances
- Biosimilar
- Sujet
-
Hu5F9-G4
Magrolimab (Hu5F9-G4) is a first-in-class humanized anti-CD47 IgG4 antibody with an anti-tumor activity. - Numéro CAS
- 2169232-81-7
-
